These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19263464)

  • 1. Design characteristics that influence attrition in geriatric antidepressant trials: meta-analysis.
    Heo M; Papademetriou E; Meyers BS
    Int J Geriatr Psychiatry; 2009 Sep; 24(9):990-1001. PubMed ID: 19263464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between probability of receiving placebo and probability of prematurely discontinuing treatment in double-blind, randomized clinical trials for MDD: a meta-analysis.
    Tedeschini E; Fava M; Goodness TM; Papakostas GI
    Eur Neuropsychopharmacol; 2010 Aug; 20(8):562-7. PubMed ID: 20219330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 4. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
    Khan A; Brodhead AE; Kolts RL; Brown WA
    J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Last-observation-carried-forward imputation method in clinical efficacy trials: review of 352 antidepressant studies.
    Woolley SB; Cardoni AA; Goethe JW
    Pharmacotherapy; 2009 Dec; 29(12):1408-16. PubMed ID: 19947800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
    Deisenhammer EA; Hinterhuber H
    Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do antidepressants work? A commentary on "Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration" by Kirsch et al.
    McAllister-Williams RH
    Evid Based Ment Health; 2008 Aug; 11(3):66-8. PubMed ID: 18669671
    [No Abstract]   [Full Text] [Related]  

  • 10. Antidepressant drug studies in the elderly.
    Rockwell E; Lam RW; Zisook S
    Psychiatr Clin North Am; 1988 Mar; 11(1):215-33. PubMed ID: 2898134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant drug therapy in the elderly--a critical review of the controlled clinical trials conducted since 1980.
    Volz HP; Möller HJ
    Pharmacopsychiatry; 1994 May; 27(3):93-100. PubMed ID: 8078956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of the new antidepressant bupropion (Wellbutrin) [proceedings].
    Halaris AE; Stern W; Harto-Truax N
    Psychopharmacol Bull; 1981 Jan; 17(1):140-2. PubMed ID: 6785817
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
    Niklson IA; Reimitz PE; Sennef C
    Psychopharmacol Bull; 1997; 33(1):41-51. PubMed ID: 9133750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are concerns about the ethics of placebos a stalking horse for other issues?
    Healy D
    Am J Bioeth; 2002; 2(2):17-9. PubMed ID: 12189063
    [No Abstract]   [Full Text] [Related]  

  • 15. Alprazolam and standard antidepressants in the treatment of depression: a meta-analysis of the antidepressant effect.
    Srisurapanont M; Boonyanaruthee V
    J Med Assoc Thai; 1997 Mar; 80(3):183-8. PubMed ID: 9175386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes for antidepressant trials in late-life depression.
    Meyers BS; Bruce ML
    Psychopharmacol Bull; 1997; 33(4):701-5. PubMed ID: 9493482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis.
    Heo M; Murphy CF; Meyers BS
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):899-905. PubMed ID: 17911366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the impact of attrition in randomized controlled trials.
    Hewitt CE; Kumaravel B; Dumville JC; Torgerson DJ;
    J Clin Epidemiol; 2010 Nov; 63(11):1264-70. PubMed ID: 20573482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-placebo difference: in antidepressant drug trials could be 50% greater than previously believed.
    Rihmer Z
    Neuropsychopharmacol Hung; 2007 Mar; 9(1):35-7. PubMed ID: 17879563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.
    Sinyor M; Levitt AJ; Cheung AH; Schaffer A; Kiss A; Dowlati Y; Lanctôt KL
    J Clin Psychiatry; 2010 Mar; 71(3):270-9. PubMed ID: 20122371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.